Following reports of a rare blood clot reaction, the Centers for Disease Control and Prevention recommended a pause in the use of the Johnson & Johnson vaccine out of “an abundance of caution.”

An active lifestyle may be one of the best defenses against COVID-19, according to a new study that revealed inactivity contributes to higher rates of death among infected patients.

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.

Physicians called on imaging societies, clinicians and news media to spread awareness about vaccine-related swollen lymph nodes.

The special enrollment period for healthcare insurance signup has proven popular after more than 528,000 people signed up for coverage on the Affordable Care Act marketplace during the first six weeks.

These blood clots have been responsible for a total of 18 deaths. Experts have continued to emphasize that the benefits of vaccination still outweigh the risks.

The pandemic made a clear impact on physician prescription and ordering practices. Will these things return to normal as more and more people continue to get vaccinated?